DEEP OCEAN Trademark

Trademark Overview


On Monday, September 16, 2024, a trademark application was filed for DEEP OCEAN with the United States Patent and Trademark Office. The USPTO has given the DEEP OCEAN trademark a serial number of 98752317. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, April 15, 2025. This trademark is owned by Longboard Pharmaceuticals, Inc.. The DEEP OCEAN trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing medical information; Providing medical information in the field of neurological and central nervous system diseases, conditions and disorders; online information services, namely, providing medical information

Scientific and technological services, namely, scientific research in the field of pharmaceutical development; Pharmaceutical research and development services; conducting clinical trials for pharmaceutical preparations; Pharmaceutical research and development services in the field of neurological and central nervous system diseases and disorders; providing medical and scientific research information in the field of clinical trials
deep ocean

General Information


Serial Number98752317
Word MarkDEEP OCEAN
Filing DateMonday, September 16, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, April 15, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 15, 2025

Trademark Statements


Goods and ServicesProviding medical information; Providing medical information in the field of neurological and central nervous system diseases, conditions and disorders; online information services, namely, providing medical information
Goods and ServicesScientific and technological services, namely, scientific research in the field of pharmaceutical development; Pharmaceutical research and development services; conducting clinical trials for pharmaceutical preparations; Pharmaceutical research and development services in the field of neurological and central nervous system diseases and disorders; providing medical and scientific research information in the field of clinical trials

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 16, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 16, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLongboard Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037

Party NameLongboard Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037

Trademark Events


Event DateEvent Description
Monday, September 16, 2024NEW APPLICATION ENTERED
Monday, September 16, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 19, 2025EXAMINERS AMENDMENT E-MAILED
Wednesday, March 19, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 19, 2025EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 19, 2025EXAMINER'S AMENDMENT ENTERED
Wednesday, March 19, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 9, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 15, 2025PUBLISHED FOR OPPOSITION
Tuesday, April 15, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, March 14, 2025ASSIGNED TO EXAMINER